Le Lézard
Classified in: Health, Science and technology
Subject: Photo/Multimedia

Experts at Infiniti Research Explain How Channeling Data Effectively Into Pharma R&D Can Help Transform the Process of Drug Development


A well-known market intelligence company, Infiniti Research, has announced the completion of its latest article on understanding the value of pharma R&D in the new era. This article covers:

"Promising innovations in the pharma market such as gene therapy and cellular therapy coupled with the rising market demand mean that there are no signs of slowing down in the sector over the next few years," says a pharma industry expert at Infiniti Research.

Big pharma has immense potential to make pharma R&D a strong contributor to value creation. Want more insights on this from our industry experts? Request a free proposal.

The biopharmaceutical industry is growing at a breakneck speed. Apart from increasingly being an innovation-driven sector, the focus in the pharma industry is now shifting towards achieving ?agility' in product development to meet customer demands effectively and shorten the time-to-market. Moreover, as pharma R&D is highly capital-intensive, a strong foundation of technical capabilities is imperative for players in the sector. Over the past decade, Pharma R&D horizons have expanded as a wider range of players are pursuing innovative therapies and solutions by leveraging a broader set of technologies. The exponential growth in the data in the pharma sector can be channeled into the R& D space. According to experts at Infiniti Research, some of the key benefits of pharma R&D include deeper patient understanding and better diagnosis, structuring better therapies, and attaining cost-effectiveness and safety.

You may also like to read some of our recent articles on the chemical industry:

Pharmaceutical companies desperately need to bolster R&D innovation and efficiency to attain long-term success. Request a free brochure to know more on we can assist your business in this.

About Infiniti Research

Established in 2003, Infiniti Research is a leading market intelligence company providing smart solutions to address your business challenges. Infiniti Research studies markets in more than 100 countries to help analyze competitive activity, see beyond market disruptions, and develop intelligent business strategies. To know more, visit:https://www.infinitiresearch.com/about-us


These press releases may also interest you

at 14:08
Concert Genetics, a technology company dedicated to advancing precision medicine, today announced the publication of real-world data on utilization and coding variability in medical claims for Next-Generation Sequencing (NGS)-based diagnostic tests....

at 14:05
"Global Orphan Drug Clinical Trials, Patent & Guidelines Insight 2026" Report Highlights:Read the full report: https://www.reportlinker.com/p05874153/?utm_source=PRN ? Global Orphan Drug Market Opportunity: US$ 300 Billion ? US Dominates Global...

at 14:00
Ambient Clinical Analytics announced today that Ambient Clinical Analytics' AWARE tm family of platforms are generally available to create local ICU extensions & Tele-ICU environments to address the surge of COVID-19 ICU demand in all hospital beds....

at 14:00
Lincoln Educational Services Corporation , a national leader in specialized automotive, skilled trades and allied health career training, announced today that several of its campuses in the Tri-State (NY, NJ & CT) area have donated medical supplies...

at 14:00
Today, March of Dimes, the nation's leader in the fight for the health of all moms and babies, is unveiling a number of services and resources at no cost for expecting and new mothers, to provide the advice and support they need as the country...

at 13:55
Caregility, a clinical collaboration and communications company focused on providing secure, reliable two-way audio and video communications for any device and clinical workflow, in both inpatient and outpatient settings, announces it has developed...



News published on 27 february 2020 at 09:20 and distributed by: